{"transactions":[{"id":740103,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T21:07:56.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":74000,"derivative":{"exercise_price":2.24,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0001543031-26-000002","document":"form4-06122026_090652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000154303126000002/form4-06122026_090652.xml","form_type":"4"}},{"id":746152,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-08T20:00:09.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":24372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":24372,"derivative":{"exercise_price":14.31,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":24372},"source":{"system":"sec-edgar","filing":"0001193125-26-261640","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526261640/ownership.xml","form_type":"4"}},{"id":1109903,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T22:24:50.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":0.6,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-25-011784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299325011784/form4.xml","form_type":"4"}},{"id":1117865,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:07:56.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":5.05,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-25-083717","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000095017025083717/ownership.xml","form_type":"4"}},{"id":1406722,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-16T20:18:18.000Z","date":"2024-09-12","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.5314,"value":7657.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.525 to $1.54. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001062993-24-016641","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299324016641/form4.xml","form_type":"4"}},{"id":1472180,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:50:51.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 20, 2025, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":2.69,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-24-012905","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299324012905/form4.xml","form_type":"4"}},{"id":1486746,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:42:52.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-070769","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000095017024070769/ownership.xml","form_type":"4"}},{"id":1514265,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T23:37:39.000Z","date":"2024-05-15","kind":"purchase","planned":false,"acquired":true,"shares":2250,"price":1.8899,"value":4252.275,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000950170-24-061294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000095017024061294/ownership.xml","form_type":"4"}},{"id":1514264,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T23:37:39.000Z","date":"2024-05-14","kind":"purchase","planned":false,"acquired":true,"shares":2750,"price":1.885,"value":5183.75,"ownership":{"direct":true},"balance_after":2750,"source":{"system":"sec-edgar","filing":"0000950170-24-061294","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000095017024061294/ownership.xml","form_type":"4"}},{"id":1842075,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-29T20:19:26.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 27, 2024, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":3.19,"expiration_date":"2024-06-27","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-23-014166","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323014166/form4.xml","form_type":"4"}},{"id":1858767,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T23:39:51.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":16985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 8, 2024 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":16985,"derivative":{"exercise_price":26.25,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":16985},"source":{"system":"sec-edgar","filing":"0000899243-23-015408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924323015408/doc4.xml","form_type":"4"}},{"id":2051081,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-19T23:16:09.000Z","date":"2023-01-18","kind":"sale","acquired":false,"shares":6923,"price":13,"value":89999.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":398532,"source":{"system":"sec-edgar","filing":"0001209191-23-004080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123004080/doc4.xml","form_type":"4"}},{"id":2051080,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-19T23:16:09.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":5000,"price":12.4889,"value":62444.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.34 to $12.70. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":405455,"source":{"system":"sec-edgar","filing":"0001209191-23-004080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123004080/doc4.xml","form_type":"4"}},{"id":2054902,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-13T22:16:22.000Z","date":"2023-01-11","kind":"tax_withholding","acquired":false,"shares":29565,"price":12.02,"value":355371.3,"ownership":{"direct":true},"balance_after":410455,"source":{"system":"sec-edgar","filing":"0001209191-23-003306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123003306/doc4.xml","form_type":"4"}},{"id":2054901,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-13T22:16:22.000Z","date":"2023-01-11","kind":"grant","acquired":true,"shares":58824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted for the achievement of the 2020 PRSU TSR goal as determined by the Compensation and Leadership Development Committee of the Board of Directors."}],"balance_after":440020,"source":{"system":"sec-edgar","filing":"0001209191-23-003306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123003306/doc4.xml","form_type":"4"}},{"id":2060770,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-06T22:05:36.000Z","date":"2023-01-04","kind":"tax_withholding","acquired":false,"shares":3884,"price":12.03,"value":46724.52,"ownership":{"direct":true},"balance_after":381196,"source":{"system":"sec-edgar","filing":"0001209191-23-002400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123002400/doc4.xml","form_type":"4"}},{"id":2068752,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-01-05T00:13:21.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":130480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant\nand the remaining 75% vesting ratably each month thereafter."}],"balance_after":130480,"derivative":{"exercise_price":11.93,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":130480},"source":{"system":"sec-edgar","filing":"0001209191-23-001394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123001394/doc4.xml","form_type":"4"}},{"id":2068751,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-05T00:13:21.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":8575,"price":11.93,"value":102299.75,"ownership":{"direct":true},"balance_after":385080,"source":{"system":"sec-edgar","filing":"0001209191-23-001394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123001394/doc4.xml","form_type":"4"}},{"id":2068750,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-05T00:13:21.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":73508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in four equal annual installments beginning on January 3, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":393655,"source":{"system":"sec-edgar","filing":"0001209191-23-001394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123001394/doc4.xml","form_type":"4"}},{"id":2068749,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-05T00:13:21.000Z","date":"2023-01-02","kind":"tax_withholding","acquired":false,"shares":15165,"price":12.21,"value":185164.65,"ownership":{"direct":true},"balance_after":320147,"source":{"system":"sec-edgar","filing":"0001209191-23-001394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123001394/doc4.xml","form_type":"4"}},{"id":2147576,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-03T20:08:09.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":39744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Century Therapeutics, Inc. (the \"Company\") issued Ms. Quimi stock options (the \"Options\") in connection with her appointment as a director. The Options vest in equal monthly installments over 36 months subject to Ms. Quimi's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan."}],"balance_after":39744,"derivative":{"exercise_price":9.89,"expiration_date":"2032-10-01","underlying":"Common Stock","underlying_shares":39744},"source":{"system":"sec-edgar","filing":"0001062993-22-020144","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299322020144/form4.xml","form_type":"4"}},{"id":2166063,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-06T21:05:31.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":4397,"price":11.2851,"value":49620.5847,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.99 to $11.57. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":335312,"source":{"system":"sec-edgar","filing":"0001209191-22-048797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122048797/doc4.xml","form_type":"4"}},{"id":2191158,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T22:02:04.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":5798,"price":12,"value":69576.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":339709,"source":{"system":"sec-edgar","filing":"0001209191-22-045060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122045060/doc4.xml","form_type":"4"}},{"id":2225816,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-21T20:01:45.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":4396,"price":9,"value":39564.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":345507,"source":{"system":"sec-edgar","filing":"0001209191-22-038365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122038365/doc4.xml","form_type":"4"}},{"id":2235911,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:05:16.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 9, 2023 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director."}],"balance_after":19000,"derivative":{"exercise_price":13.56,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0000899243-22-021886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322021886/doc4.xml","form_type":"4"}},{"id":2432519,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-19T23:42:24.000Z","date":"2022-01-14","kind":"tax_withholding","acquired":false,"shares":18843,"price":10.53,"value":198416.79,"ownership":{"direct":true},"balance_after":349903,"source":{"system":"sec-edgar","filing":"0001209191-22-003818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122003818/doc4.xml","form_type":"4"}},{"id":2432518,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-19T23:42:24.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":36840,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted for the achievement of the 2019 PRSU TSR goal as determined by the Board of Directors."}],"balance_after":368746,"source":{"system":"sec-edgar","filing":"0001209191-22-003818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122003818/doc4.xml","form_type":"4"}},{"id":2438911,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-11T01:31:20.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":8400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the date of the Corporation's 2022 Annual Stockholders Meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":8400,"derivative":{"exercise_price":19,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":8400},"source":{"system":"sec-edgar","filing":"0000899243-22-001517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000089924322001517/doc4.xml","form_type":"4"}},{"id":2450110,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-01-05T02:01:33.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":134044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant\nand the remaining 75% vesting ratably each month thereafter."}],"balance_after":134044,"derivative":{"exercise_price":12.11,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":134044},"source":{"system":"sec-edgar","filing":"0001209191-22-001205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001205/doc4.xml","form_type":"4"}},{"id":2450109,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:01:33.000Z","date":"2022-01-04","kind":"tax_withholding","acquired":false,"shares":4041,"price":12.48,"value":50431.68,"ownership":{"direct":true},"balance_after":331906,"source":{"system":"sec-edgar","filing":"0001209191-22-001205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001205/doc4.xml","form_type":"4"}},{"id":2450108,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:01:33.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":73136,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units will vest in four equal annual installments beginning on January 3, 2023."}],"balance_after":335947,"source":{"system":"sec-edgar","filing":"0001209191-22-001205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001205/doc4.xml","form_type":"4"}},{"id":2450107,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:01:33.000Z","date":"2022-01-03","kind":"tax_withholding","acquired":false,"shares":1538,"price":12.11,"value":18625.18,"ownership":{"direct":true},"balance_after":262811,"source":{"system":"sec-edgar","filing":"0001209191-22-001205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001205/doc4.xml","form_type":"4"}},{"id":2450106,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:01:33.000Z","date":"2022-01-02","kind":"tax_withholding","acquired":false,"shares":15778,"price":11.55,"value":182235.9,"ownership":{"direct":true},"balance_after":264349,"source":{"system":"sec-edgar","filing":"0001209191-22-001205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001205/doc4.xml","form_type":"4"}},{"id":2450105,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:01:33.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":10502,"price":11.55,"value":121298.1,"ownership":{"direct":true},"balance_after":280127,"source":{"system":"sec-edgar","filing":"0001209191-22-001205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001205/doc4.xml","form_type":"4"}},{"id":2753208,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-09T00:01:37.000Z","date":"2021-04-06","kind":"grant","acquired":true,"shares":19295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units for the achievement of the 2019 PRSU Revenue goal. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock. The Restricted Stock Units will vest on December 31, 2021, subject to the reporting person's continued service with the Company."}],"balance_after":290629,"source":{"system":"sec-edgar","filing":"0001209191-21-026161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121026161/doc4.xml","form_type":"4"}},{"id":2800351,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-03-09T22:38:33.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":16628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":2.94,"expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":16628},"source":{"system":"sec-edgar","filing":"0001209191-21-019155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121019155/doc4.xml","form_type":"4"}},{"id":2800350,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-09T22:38:33.000Z","date":"2021-03-05","kind":"tax_withholding","acquired":false,"shares":4664,"price":10.48,"value":48878.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares exchanged to cover the strike price of the options exercised."}],"balance_after":271334,"source":{"system":"sec-edgar","filing":"0001209191-21-019155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121019155/doc4.xml","form_type":"4"}},{"id":2800349,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-09T22:38:33.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":16628,"price":2.94,"value":48886.32,"ownership":{"direct":true},"balance_after":275998,"source":{"system":"sec-edgar","filing":"0001209191-21-019155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121019155/doc4.xml","form_type":"4"}},{"id":2902644,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-20T23:17:05.000Z","date":"2021-01-15","kind":"tax_withholding","acquired":false,"shares":4770,"price":21.835,"value":104152.95,"ownership":{"direct":true},"balance_after":259370,"source":{"system":"sec-edgar","filing":"0001209191-21-004472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121004472/doc4.xml","form_type":"4"}},{"id":2902643,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-20T23:17:05.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":9502,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted for the achievement of the 2018 PRSU TSR goal as determined by the Compensation and Leadership Development Committee of the Board of Directors."}],"balance_after":264140,"source":{"system":"sec-edgar","filing":"0001209191-21-004472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121004472/doc4.xml","form_type":"4"}},{"id":2921522,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-01-06T00:43:34.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":53355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant\nand the remaining 75% vesting ratably each month thereafter."}],"balance_after":53355,"derivative":{"exercise_price":21.78,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":53355},"source":{"system":"sec-edgar","filing":"0001209191-21-001653","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121001653/doc4.xml","form_type":"4"}},{"id":2921521,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-06T00:43:34.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":33131,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units will vest in four equal annual installments beginning on January 4, 2022."}],"balance_after":254638,"source":{"system":"sec-edgar","filing":"0001209191-21-001653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121001653/doc4.xml","form_type":"4"}},{"id":2921520,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-06T00:43:34.000Z","date":"2021-01-03","kind":"tax_withholding","acquired":false,"shares":5053,"price":23.09,"value":116673.77,"ownership":{"direct":true},"balance_after":221507,"source":{"system":"sec-edgar","filing":"0001209191-21-001653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121001653/doc4.xml","form_type":"4"}},{"id":2921519,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-06T00:43:34.000Z","date":"2021-01-02","kind":"tax_withholding","acquired":false,"shares":15164,"price":23.09,"value":350136.76,"ownership":{"direct":true},"balance_after":226560,"source":{"system":"sec-edgar","filing":"0001209191-21-001653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121001653/doc4.xml","form_type":"4"}},{"id":2921518,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-06T00:43:34.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":2620,"price":23.09,"value":60495.8,"ownership":{"direct":true},"balance_after":241724,"source":{"system":"sec-edgar","filing":"0001209191-21-001653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121001653/doc4.xml","form_type":"4"}},{"id":2933289,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-12-23T22:45:24.000Z","date":"2020-12-21","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":16628,"derivative":{"exercise_price":2.94,"expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-065059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120065059/doc4.xml","form_type":"4"}},{"id":2933288,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-23T22:45:24.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":5000,"price":24.0947,"value":120473.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $23.60 to $24.45. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":244344,"source":{"system":"sec-edgar","filing":"0001209191-20-065059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120065059/doc4.xml","form_type":"4"}},{"id":2933287,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-23T22:45:24.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":5000,"price":2.94,"value":14700.0,"ownership":{"direct":true},"balance_after":249344,"source":{"system":"sec-edgar","filing":"0001209191-20-065059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120065059/doc4.xml","form_type":"4"}},{"id":2940475,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-12-17T21:32:12.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":6892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":2.45,"expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":6892},"source":{"system":"sec-edgar","filing":"0001209191-20-064062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120064062/doc4.xml","form_type":"4"}},{"id":2940474,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-12-17T21:32:12.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":4379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":3.53,"expiration_date":"2023-01-28","underlying":"Common Stock","underlying_shares":4379},"source":{"system":"sec-edgar","filing":"0001209191-20-064062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120064062/doc4.xml","form_type":"4"}},{"id":2940473,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-12-17T21:32:12.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":7550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":4.38,"expiration_date":"2022-06-04","underlying":"Common Stock","underlying_shares":7550},"source":{"system":"sec-edgar","filing":"0001209191-20-064062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120064062/doc4.xml","form_type":"4"}},{"id":2940472,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-12-17T21:32:12.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":21628,"derivative":{"exercise_price":2.94,"expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001209191-20-064062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120064062/doc4.xml","form_type":"4"}},{"id":2940471,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-17T21:32:12.000Z","date":"2020-12-15","kind":"tax_withholding","acquired":false,"shares":4156,"price":23.86,"value":99162.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares swapped to cover the strike price of the options exercised."}],"balance_after":244344,"source":{"system":"sec-edgar","filing":"0001209191-20-064062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120064062/doc4.xml","form_type":"4"}},{"id":2940470,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-17T21:32:12.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":6892,"price":2.45,"value":16885.4,"ownership":{"direct":true},"balance_after":248500,"source":{"system":"sec-edgar","filing":"0001209191-20-064062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120064062/doc4.xml","form_type":"4"}},{"id":2940469,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-17T21:32:12.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":4379,"price":3.53,"value":15457.87,"ownership":{"direct":true},"balance_after":241608,"source":{"system":"sec-edgar","filing":"0001209191-20-064062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120064062/doc4.xml","form_type":"4"}},{"id":2940468,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-17T21:32:12.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":7550,"price":4.38,"value":33069.0,"ownership":{"direct":true},"balance_after":237229,"source":{"system":"sec-edgar","filing":"0001209191-20-064062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120064062/doc4.xml","form_type":"4"}},{"id":2940467,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-17T21:32:12.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":11500,"price":2.94,"value":33810.0,"ownership":{"direct":true},"balance_after":229679,"source":{"system":"sec-edgar","filing":"0001209191-20-064062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120064062/doc4.xml","form_type":"4"}},{"id":3013664,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-10-05T21:10:57.000Z","date":"2020-10-02","kind":"exercise","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":6892,"derivative":{"exercise_price":2.45,"expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-20-053728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120053728/doc4.xml","form_type":"4"}},{"id":3013663,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-10-05T21:10:57.000Z","date":"2020-10-01","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":33128,"derivative":{"exercise_price":2.94,"expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-053728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120053728/doc4.xml","form_type":"4"}},{"id":3013662,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-05T21:10:57.000Z","date":"2020-10-02","kind":"exercise","acquired":true,"shares":11000,"price":2.45,"value":26950.0,"ownership":{"direct":true},"balance_after":218179,"source":{"system":"sec-edgar","filing":"0001209191-20-053728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120053728/doc4.xml","form_type":"4"}},{"id":3013661,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-05T21:10:57.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":5000,"price":14.0198,"value":70099.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.87 to $14.31. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":207179,"source":{"system":"sec-edgar","filing":"0001209191-20-053728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120053728/doc4.xml","form_type":"4"}},{"id":3013660,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-05T21:10:57.000Z","date":"2020-10-01","kind":"exercise","acquired":true,"shares":5000,"price":2.94,"value":14700.0,"ownership":{"direct":true},"balance_after":212179,"source":{"system":"sec-edgar","filing":"0001209191-20-053728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120053728/doc4.xml","form_type":"4"}},{"id":3089154,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-07-06T23:38:56.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":6872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":28128,"derivative":{"exercise_price":2.94,"expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":6872},"source":{"system":"sec-edgar","filing":"0001104659-20-081467","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000110465920081467/a4.xml","form_type":"4"}},{"id":3089153,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-07-06T23:38:56.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the options were fully vested and exercisable as of the transaction date."}],"balance_after":17892,"derivative":{"exercise_price":2.45,"expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001104659-20-081467","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000110465920081467/a4.xml","form_type":"4"}},{"id":3089152,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-06T23:38:56.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":6872,"price":15.4723,"value":106325.6456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.06 to $15.68. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":207179,"source":{"system":"sec-edgar","filing":"0001104659-20-081467","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000110465920081467/a4.xml","form_type":"4"}},{"id":3089151,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-06T23:38:56.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":6872,"price":2.94,"value":20203.68,"ownership":{"direct":true},"balance_after":214051,"source":{"system":"sec-edgar","filing":"0001104659-20-081467","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000110465920081467/a4.xml","form_type":"4"}},{"id":3089150,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-06T23:38:56.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":13000,"price":2.45,"value":31850.0,"ownership":{"direct":true},"balance_after":207179,"source":{"system":"sec-edgar","filing":"0001104659-20-081467","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000110465920081467/a4.xml","form_type":"4"}},{"id":3107410,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-18T00:34:50.000Z","date":"2020-06-15","kind":"tax_withholding","acquired":false,"shares":1046,"price":11.14,"value":11652.44,"ownership":{"direct":true},"balance_after":194179,"source":{"system":"sec-edgar","filing":"0001209191-20-037473","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120037473/doc4.xml","form_type":"4"}},{"id":3183878,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-03T22:47:59.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":4803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units for the achievement of the 2018 PRSU Revenue goal. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock. The Restricted Stock Units will vest on December 31, 2020, subject to the reporting person's continued service with the Company."}],"balance_after":195225,"source":{"system":"sec-edgar","filing":"0001209191-20-023450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120023450/doc4.xml","form_type":"4"}},{"id":3311772,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-15T01:36:50.000Z","date":"2020-01-10","kind":"tax_withholding","acquired":false,"shares":12065,"price":9.46,"value":114134.9,"ownership":{"direct":true},"balance_after":190422,"source":{"system":"sec-edgar","filing":"0001209191-20-003379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003379/doc4.xml","form_type":"4"}},{"id":3311771,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-15T01:36:50.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":24496,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted for the achievement of the 2017 PRSU TSR goal as determined by the Compensation Committee of the Board of Directors."}],"balance_after":202487,"source":{"system":"sec-edgar","filing":"0001209191-20-003379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003379/doc4.xml","form_type":"4"}},{"id":3313705,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-01-10T22:27:10.000Z","date":"2020-01-09","kind":"exercise","acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these options were fully vested and exercisable as of January 9, 2020."}],"balance_after":7550,"derivative":{"exercise_price":4.38,"expiration_date":"2022-06-04","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001209191-20-003091","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003091/doc4.xml","form_type":"4"}},{"id":3313704,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-01-10T22:27:10.000Z","date":"2020-01-09","kind":"exercise","acquired":false,"shares":9822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these options were fully vested and exercisable as of January 9, 2020."}],"balance_after":0,"derivative":{"exercise_price":2.52,"expiration_date":"2023-06-18","underlying":"Common Stock","underlying_shares":9822},"source":{"system":"sec-edgar","filing":"0001209191-20-003091","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003091/doc4.xml","form_type":"4"}},{"id":3313703,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-10T22:27:10.000Z","date":"2020-01-09","kind":"exercise","acquired":true,"shares":1200,"price":4.38,"value":5256.0,"ownership":{"direct":true},"balance_after":177991,"source":{"system":"sec-edgar","filing":"0001209191-20-003091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003091/doc4.xml","form_type":"4"}},{"id":3313702,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-10T22:27:10.000Z","date":"2020-01-09","kind":"exercise","acquired":true,"shares":9822,"price":2.52,"value":24751.44,"ownership":{"direct":true},"balance_after":176791,"source":{"system":"sec-edgar","filing":"0001209191-20-003091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003091/doc4.xml","form_type":"4"}},{"id":3313701,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-10T22:27:10.000Z","date":"2020-01-09","kind":"sale","acquired":false,"shares":15000,"price":9.9301,"value":148951.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $9.93 to $9.94. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":166969,"source":{"system":"sec-edgar","filing":"0001209191-20-003091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120003091/doc4.xml","form_type":"4"}},{"id":3318752,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-07T00:38:11.000Z","date":"2020-01-03","kind":"tax_withholding","acquired":false,"shares":5305,"price":9.18,"value":48699.9,"ownership":{"direct":true},"balance_after":181969,"source":{"system":"sec-edgar","filing":"0001209191-20-002153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120002153/doc4.xml","form_type":"4"}},{"id":3318751,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-07T00:38:11.000Z","date":"2020-01-02","kind":"tax_withholding","acquired":false,"shares":7113,"price":9.55,"value":67929.15,"ownership":{"direct":true},"balance_after":187274,"source":{"system":"sec-edgar","filing":"0001209191-20-002153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120002153/doc4.xml","form_type":"4"}},{"id":3323670,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-01-03T22:18:21.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":112954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on the first anniversary of the grant date. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments beginning on the first month thereafter."}],"balance_after":112954,"derivative":{"exercise_price":9.55,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":112954},"source":{"system":"sec-edgar","filing":"0001209191-20-001215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120001215/doc4.xml","form_type":"4"}},{"id":3323669,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-03T22:18:21.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":71868,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units will vest in four equal annual installments beginning on January 2, 2021."}],"balance_after":194387,"source":{"system":"sec-edgar","filing":"0001209191-20-001215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120001215/doc4.xml","form_type":"4"}},{"id":3323668,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-03T22:18:21.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":6735,"price":9.74,"value":65598.9,"ownership":{"direct":true},"balance_after":122519,"source":{"system":"sec-edgar","filing":"0001209191-20-001215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919120001215/doc4.xml","form_type":"4"}},{"id":3486424,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-19T01:16:53.000Z","date":"2019-06-17","kind":"tax_withholding","acquired":false,"shares":1046,"price":11.35,"value":11872.1,"ownership":{"direct":true},"balance_after":129254,"source":{"system":"sec-edgar","filing":"0001209191-19-037869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919119037869/doc4.xml","form_type":"4"}},{"id":3555967,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2019-04-15T23:57:49.000Z","date":"2019-04-11","kind":"grant","acquired":true,"shares":12347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units for the achievement of the 2017 PRSU clinical goal. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock. The Restricted Stock Units will vest on December 31, 2019, subject to the reporting person's continued service with the Company."}],"balance_after":130300,"source":{"system":"sec-edgar","filing":"0001209191-19-024668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919119024668/doc4.xml","form_type":"4"}},{"id":3698300,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2019-01-10T23:12:44.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":88154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on the first anniversary of the grant date. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments beginning on the first month thereafter."}],"balance_after":88154,"derivative":{"exercise_price":10.04,"expiration_date":"2029-01-02","underlying":"Common stock","underlying_shares":88154},"source":{"system":"sec-edgar","filing":"0001209191-19-003317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919119003317/doc4.xml","form_type":"4"}},{"id":3698299,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2019-01-10T23:12:44.000Z","date":"2019-01-03","kind":"tax_withholding","acquired":false,"shares":3850,"price":10.33,"value":39770.5,"ownership":{"direct":true},"balance_after":117953,"source":{"system":"sec-edgar","filing":"0001209191-19-003317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919119003317/doc4.xml","form_type":"4"}},{"id":3698298,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2019-01-10T23:12:44.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":57471,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Restricted Stock Units will vest in four equal annual installments beginning on January 2, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock."}],"balance_after":121803,"source":{"system":"sec-edgar","filing":"0001209191-19-003317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919119003317/doc4.xml","form_type":"4"}},{"id":4001214,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Stock Options (right to buy)","published_at":"2018-03-12T22:04:21.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the options were fully vested and exercisable as of March 9, 2018."}],"balance_after":0,"derivative":{"exercise_price":5.96,"expiration_date":"2021-01-19","underlying":"Common stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001209191-18-018938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118018938/doc4.xml","form_type":"4"}},{"id":4001213,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common stock","published_at":"2018-03-12T22:04:21.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":8750,"price":15,"value":131250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017."}],"balance_after":64332,"source":{"system":"sec-edgar","filing":"0001209191-18-018938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118018938/doc4.xml","form_type":"4"}},{"id":4001212,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common stock","published_at":"2018-03-12T22:04:21.000Z","date":"2018-03-09","kind":"exercise","acquired":true,"shares":8750,"price":5.96,"value":52150.0,"ownership":{"direct":true},"balance_after":73082,"source":{"system":"sec-edgar","filing":"0001209191-18-018938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118018938/doc4.xml","form_type":"4"}},{"id":4015846,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Stock Options (right to buy)","published_at":"2018-03-05T22:55:50.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":8149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the options were fully vested and exercisable as of March 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":4.16,"expiration_date":"2019-11-16","underlying":"Common stock","underlying_shares":8149},"source":{"system":"sec-edgar","filing":"0001209191-18-016786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118016786/doc4.xml","form_type":"4"}},{"id":4015845,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common stock","published_at":"2018-03-05T22:55:50.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":8149,"price":14.0553,"value":114536.6397,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.11 to $14.53. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":64332,"source":{"system":"sec-edgar","filing":"0001209191-18-016786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118016786/doc4.xml","form_type":"4"}},{"id":4015844,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common stock","published_at":"2018-03-05T22:55:50.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":8149,"price":4.16,"value":33899.84,"ownership":{"direct":true},"balance_after":72481,"source":{"system":"sec-edgar","filing":"0001209191-18-016786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118016786/doc4.xml","form_type":"4"}},{"id":4105687,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Stock Options (right to buy)","published_at":"2018-01-05T23:37:06.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":18224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 3, 2019. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2019, with the final installment vesting on January 1, 2022."}],"balance_after":18224,"derivative":{"exercise_price":15.67,"expiration_date":"2028-01-03","underlying":"Common stock","underlying_shares":18224},"source":{"system":"sec-edgar","filing":"0001209191-18-002550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002550/doc4.xml","form_type":"4"}},{"id":4105686,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common stock","published_at":"2018-01-05T23:37:06.000Z","date":"2018-01-03","kind":"tax_withholding","acquired":false,"shares":2953,"price":15.67,"value":46273.51,"ownership":{"direct":true},"balance_after":64332,"source":{"system":"sec-edgar","filing":"0001209191-18-002550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002550/doc4.xml","form_type":"4"}},{"id":4105685,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common stock","published_at":"2018-01-05T23:37:06.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":12609,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":67285,"source":{"system":"sec-edgar","filing":"0001209191-18-002550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002550/doc4.xml","form_type":"4"}},{"id":4107762,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Stock Options (right to buy)","published_at":"2018-01-04T22:10:19.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017."}],"balance_after":0,"derivative":{"exercise_price":10.36,"exercise_date":"2010-02-03","expiration_date":"2019-02-03","underlying":"Common stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-18-002051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002051/doc4.xml","form_type":"4"}},{"id":4107761,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common stock","published_at":"2018-01-04T22:10:19.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":8000,"price":14.7154,"value":117723.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price is the weighted average sale price for the transactions reported on this line.  The prices for the transactions reported on this line range from $14.12 to $15.16.  The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":54676,"source":{"system":"sec-edgar","filing":"0001209191-18-002051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002051/doc4.xml","form_type":"4"}},{"id":4107760,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common stock","published_at":"2018-01-04T22:10:19.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":8000,"price":14.7154,"value":117723.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average purchase price for the transactions reported on this line.  The prices for the transactions reported on this line range from $14.12 to $15.16.  The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":62676,"source":{"system":"sec-edgar","filing":"0001209191-18-002051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919118002051/doc4.xml","form_type":"4"}},{"id":4185880,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Stock Options (right to buy)","published_at":"2017-10-17T01:07:50.000Z","date":"2017-10-12","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017."}],"balance_after":0,"derivative":{"exercise_price":10.21,"exercise_date":"2012-02-05","expiration_date":"2018-02-05","underlying":"Common stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-17-057053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919117057053/doc4.xml","form_type":"4"}},{"id":4185879,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":38806,"kind":"person","name":"Quimi Daphne","position":1,"cik":"0001543031","reported_name":"Quimi Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common stock","published_at":"2017-10-17T01:07:50.000Z","date":"2017-10-12","kind":"sale","acquired":false,"shares":7000,"price":14.2485,"value":99739.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price is the weighted average sale price for the transactions reported on this line.  The prices for the transactions reported on this line range from $14.10 to $14.43.  The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":54676,"source":{"system":"sec-edgar","filing":"0001209191-17-057053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919117057053/doc4.xml","form_type":"4"}}],"next_cursor":"2017-10-17T01:07:50.000000Z,4185879"}